Dr. Teitelbaum returns to LNH to speak with Mark Alyn.Last year, the NIH funding for fibromyalgia was $12 million.
Meanwhile, Principal Deputy Director Dr. Larry Tabak recently noted that they will allocate $1.15 billion to study the long-term effects of the COVID-19 virus.
“As noted by Dr. Fauci, much of what people experience as ‘long hauler syndrome’ following a bout with the coronavirus is actually post-viral Chronic Fatigue Syndrome (CFS) and fibromyalgia,” explains CFS researcher and board-certified internist Jacob Teitelbaum, MD. His landmark research on effective treatment for CFS and its painful cousin fibromyalgia was published nearly 20 years ago in The Journal of Chronic Fatigue Syndrome (8:2,2001). Dr. Teitelbaum returns to LNH to visit with Mark Alyn.